The Claim
High-density Ki-67 staining (3+) in bronchial tissue decreased by 46% in former smokers taking 120 μmol of sulforaphane daily for 12 months, compared to a 99% increase in the placebo group, indicating a targeted suppression of highly proliferative cell populations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Former smokers who took 120 micromoles of sulforaphane daily for 12 months showed a 46% reduction in high-density Ki-67 staining in bronchial tissue, while those who took a placebo showed a 99% increase.
See the scientific wording
High-density Ki-67 staining (3+) in bronchial tissue decreased by 46% in former smokers taking 120 μmol of sulforaphane daily for 12 months, compared to a 99% increase in the placebo group, indicating a targeted suppression of highly proliferative cell populations.
Sulforaphane enters cells in the airways and turns on a defense system that cleans up harmful chemicals and repairs damaged DNA. This stops the cells from dividing too fast, which reduces the number of cells showing signs of rapid growth.
What the research says
1 studyIn former heavy smokers, taking sulforaphane daily for a year cut down the number of super-fast-dividing cells in the airways, while those taking a placebo saw those cells multiply even more. This suggests sulforaphane may help prevent lung cancer by slowing down dangerous cell growth.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.